Prof. Resia Pretorius and Dr. Douglas Kell's research reveals why long COVID can induce blood clotting issues, focusing on abnormal clots and the protein galectin-3. Their findings suggest potential treatments, such as targeting galectin-3 and repurposing amyloid therapies, while emphasizing the need for further study on long COVID's implications for millions affected.
Long Covid Journey 